KPIs & Operating Metrics(New)
Breakdown Of AssetsCollaborative Agreement Revenue BreakdownCollaborative Agreement Revenue Breakdown AnnualCommercial Revenue By CategoryCommercial Revenue By Category AnnualContractual Obligations AnnualContractual Obligations TotalCost Of SalesDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income TaxNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty, Plant And Equipment, Net BreakdownRaw Materials By SegmentR&D Revenue By CategoryR&D Revenue By Category AnnualR&D Revenue By Category (Deprecated)Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Gross Profit: 2009-2024

Historic Gross Profit for Ionis Pharmaceuticals (IONS) over the last 16 years, with Dec 2024 value amounting to $693.9 million.

  • Ionis Pharmaceuticals' Gross Profit rose 16.30% to $154.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $781.1 million, marking a year-over-year decrease of 1.45%. This contributed to the annual value of $693.9 million for FY2024, which is 10.87% down from last year.
  • According to the latest figures from FY2024, Ionis Pharmaceuticals' Gross Profit is $693.9 million, which was down 10.87% from $778.5 million recorded in FY2023.
  • Ionis Pharmaceuticals' Gross Profit's 5-year high stood at $778.5 million during FY2023, with a 5-year trough of $49.2 million in FY2021.
  • Over the past 3 years, Ionis Pharmaceuticals' median Gross Profit value was $693.9 million (recorded in 2024), while the average stood at $681.9 million.
  • In the last 5 years, Ionis Pharmaceuticals' Gross Profit surged by 2,242.95% in 2020 and then plummeted by 93.15% in 2021.
  • Over the past 5 years, Ionis Pharmaceuticals' Gross Profit (Yearly) stood at $717.3 million in 2020, then crashed by 93.15% to $49.2 million in 2021, then soared by 1,066.14% to $573.3 million in 2022, then spiked by 35.81% to $778.5 million in 2023, then declined by 10.87% to $693.9 million in 2024.